CBLL
HealthcareCeriBell, Inc.
$20.81
$-0.49 (-2.30%)
Jan 5, 2026
Price History (1Y)
Analysis
CeriBell, Inc. is a healthcare company in the medical devices industry with 281 employees. It has a market capitalization of $771.96 million and generates revenue of $82.81 million on a trailing twelve-month basis. The company's financial health is a concern, with negative profitability metrics across the board. The operating margin stands at -64.8%, while the profit margin is -63.3%. Return on equity (ROE) is -59.8% and return on assets (ROA) is -28.7%. On the balance sheet side, CeriBell has $168.54 million in cash and $21.34 million in debt, resulting in a debt-to-equity ratio of 13.01. CeriBell's valuation metrics are also unfavorable, with a forward P/E ratio of -14.24 and an EV/EBITDA ratio of -11.63. The price to book ratio is 4.70, while the price to sales ratio is 9.32. Revenue growth has been strong at 31.4% year-over-year, but earnings growth is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Visit website →Key Statistics
- Market Cap
- $771.96M
- P/E Ratio
- N/A
- 52-Week High
- $26.04
- 52-Week Low
- $10.01
- Avg Volume
- 431.47K
Company Info
- Industry
- Medical Devices
- Exchange
- NMS
- Country
- United States
- Employees
- 281